Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-01-16 @ 3:14 PM
Study NCT ID:
NCT02069535
Status:
COMPLETED
Last Update Posted:
2015-01-06
First Post:
2014-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy
Sponsor:
ALK-Abelló A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04
Start Date Type:
None
Primary Completion Date:
2014-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-18
First Submit QC Date:
None
Study First Post Date:
2014-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-05
Last Update Post Date:
2015-01-06
Last Update Post Date Type:
ESTIMATED